Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Crit Rev Oncol Hematol ; 186: 103988, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37086955

ABSTRACT

Traditional therapeutic approaches for malignant melanoma, have proved to be limited and/or ineffective, especially with respect to their role in improving patient survival and tumor recurrence. In this regard, immunotherapy has been demonstrated to be a promising therapeutic alternative, boosting antitumor responses through the modulation of cell signaling pathways involved in the effector mechanisms of the immune system, particularly, the so-called "immunological checkpoints". Clinical studies on the efficacy and safety of immunotherapeutic regimens, alone or in combination with other antitumor approaches, have increased dramatically in recent decades, with very encouraging results. Hence, this review will discuss the current immunotherapeutic regimens used to treat malignant melanoma, as well as the molecular and cellular mechanisms involved. In addition, current clinical studies that have investigated the use, efficacy, and adverse events of immunotherapy in melanoma will also be discussed.


Subject(s)
Melanoma , Skin Neoplasms , Humans , Melanoma/drug therapy , Skin Neoplasms/genetics , Skin Neoplasms/therapy , Immunotherapy/methods , Melanoma, Cutaneous Malignant
SELECTION OF CITATIONS
SEARCH DETAIL